Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue

Modern Pathology

Volumn 17, Issue 6, 2004, Pages 684-689

  Jüttner, Stefan ^a,f   Vieth, Michael ^b   Miehlke, Stephan ^c   Schneider Brachert, Wulf ^d   Kirsch, Christian ^c   Pfeuffer, Thilo ^e   Lehn, Norbert ^d   Stolte, Manfred ^a  

^a INSTITUTE OF PATHOLOGY   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e CREATOGEN AG   (Germany)

^f Private Group Praxis for Pathology   (Germany)

Author keywords

FISH; Formalin fixed tissue; Helicobacter pylori; Macrolide resistance; Resistance testing

Indexed keywords

AGAR; FORMALDEHYDE; MACROLIDE; PARAFFIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; DILUTION; FLUORESCENCE IN SITU HYBRIDIZATION; GASTRITIS; GASTROSCOPY; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; STOMACH BIOPSY; TISSUE FIXATION; TISSUE PREPARATION;

ANTI-BACTERIAL AGENTS; CARBOCYANINES; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; FLUORESCEIN; FORMALDEHYDE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MACROLIDES; REPRODUCIBILITY OF RESULTS; STOMACH; TISSUE FIXATION;

EID: 2642576717     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800098     Document Type: Article

References (36)

1. Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992;102:720-727.
2. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-2115.
3. Malfertheiner P, Bayerdorffer E, Diete U, et al. The GUMACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther 1999; 13:703-712.
4. Morgner A, Thiede C, Bayerdorffer E, et al. Long-term Follow-up of gastric MALT lymphoma after H. pylori Eradication. Curr Gastroenterol Rep 2001;3:516-522.
5. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-180.
6. Miehlke S, Bayerdorffer E, Graham DY. Treatment of Helicobacter pylori infection. Semin Gastrointest Dis 2001;12:167-179.
7. Cohen ML. Changing patterns of infectious disease. Nature 2000;406:762-767.
8. Megraud F. Resistance of Helicobacter pylori to antibiotics and its impact on treatment options. Drug Resist Updat 2001;4:178-186.
9. Ellenrieder V, Boeck W, Richter C, et al. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. Scand J Gastroenterol 1999;34:750-756.
10. Heep M, Kist M, Strobel S, et al. Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis 2000;19: 538-541.
11. Peitz U, Sulliga M, Wolle K, et al. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther 2002; 16:315-324.
12. Lahaie RG, Gaudreau C. Helicobacter pylori antibiotic resistance: trends over time. Can J Gastroenterol 2000; 14:895-899.
13. Glupczynski Y, Megraud F, Lopez-Brea M, et al. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2001;20:820-823.
14. Heep M, Scheibl K, Degrell A, et al. Transport and storage of fresh and frozen gastric biopsy specimens for optimal recovery of Helicobacter pylori. J Clin Microbiol 1999;37:3764-3766.
15. Owen RJ. Molecular testing for antibiotic resistance in Helicobacter pylori. Gut 2002;50:285-289.
16. Debets-Ossenkopp YJ, Sparrius M, Kusters JG, et al. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett 1996;142:37-42.
17. Versalovic J, Shortridge D, Kibler K, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996;40:477-480.
18. Trebesius K, Panthel K, Strobel S, et al. Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut 2000;46:608-614.
19. Miehlke S, Kirsch C, Schneider-Brachert W, et al. A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter 2003;8:310-319.
20. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The Updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20: 1161-1181.
21. Feydt-Schmidt A, Russmann H, Lehn N, et al. Fluorescence in situ hybridization vs epsilometer test for detection of clarithromycin-susceptible and clarithromycin-resistant Helicobacter pylori strains in gastric biopsies from children. Aliment Pharmacol Ther 2002;16:2073-2079.
22. Russmann H, Adler K, Haas R, et al. Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization. J Clin Microbiol 2001; 39:4142-4144.
23. Russmann H, Kempf VA, Koletzko S, et al. Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens. J Clin Microbiol 2001;39: 304-308.
24. Alarcon T, Domingo D, Prieto N, et al. PCR using 3′-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. J Clin Microbiol 2000;38:923-925.
25. Chisholm SA, Owen RJ, Teare EL, et al. PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples. J Clin Microbiol 2001;39:1217-1220.
26. Gibson JR, Saunders NA, Burke B, et al. Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori. J Clin Microbiol 1999;37: 3746-3748.
27. Maeda S, Yoshida H, Matsunaga, et al. Detection of clarithromycin-resistant Helicobacter pylori strains by a preferential homoduplex formation assay. J Clin Microbiol 2000;38:210-214.
28. Marais A, Monteiro L, Occhialini A, et al. Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens. Gut 1999;44:463-467.
29. Matsuoka M, Yoshida Y, Hayakawa K, et al. Simultaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure. Gut 1999;45:503-507.
30. Pina M, Occhialini A, Monteiro L, et al. Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase. J Clin Microbiol 1998;36:3285-3290.
31. Ryan KA, van Doorn LJ, Moran AP, et al. Evaluation of clarithromycin resistance and caga and vaca genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays. J Clin Microbiol 2001;39:1978-1980.
32. Sevin E, Lamarque D, Delchier JC, et al. Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR. FEMS Microbiol Lett 1998;165: 369-372.
33. Stone GG, Shortridge D, Versalovic J, et al. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother 1997;41:712-714.
34. van Doorn LJ, Debets-Ossenkopp YJ, Marais A, et al. Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob Agents Chemother 1999;43:1779-1782.
35. Taylor NS, Fox JG, Akopyants NS, et al. Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting. J Clin Microbiol 1995;33:918-923.
36. Wang G, Jiang Q, Taylor DE. Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates. J Clin Microbiol 1998;36:2730-2731.